BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Syndax to Participate in the BTIG Biotechnology Conference

  Syndax Pharmaceuticals, Inc. announced that Briggs W. Morrison, M.D., Chief Executive Officer of Syndax, will participate in a panel discussion on targeted oncology therapies at the BTIG Biotechnology Conference on Monday, August 12, 2019 at 4:00 p.m. ET at the St. Regis New York.

  August 5, 2019

   · 

  1 min read
• @BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally

  Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB, an application that uses Amazon Web Service Cloud and artificial intelligence technologies to enable quick and easy counting of bacterial colonies, is now available to overseas users of CompactDry.

  August 5, 2019

   · 

  2 min read
• Business

  Amneal Reports Second Quarter 2019 Financial Results

  Amneal Pharmaceuticals, Inc. announced its results for the second quarter ended June 30, 2019.

  August 5, 2019

   · 

  21 min read
• Business

  Compugen Reports Second Quarter 2019 Results

  Compugen Ltd. reported financial results for the second quarter ended June 30, 2019.

  August 5, 2019

   · 

  7 min read
• Drug Development

  Altavant Sciences Initiates Phase 2a Study of Rodatristat Ethyl in Pulmonary Arterial Hypertension

  The study is designed to provide valuable safety, target engagement and biomarker information, which will be used to inform a comprehensive Phase 2b efficacy study of rodatristat ethyl in PAH.

  August 5, 2019

   · 

  4 min read
• Business

  Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results

  Conference Call and Webcast Today at 8:30 a.m. EST / 5:30 a.m. PST

  August 5, 2019

   · 

  8 min read
• Drug Development

  NanoViricides Reports Its First Drug Candidate is on Track with GLP Safety/Toxicology Studies toward Human Clinical Trials

  The Company reports that NV-HHV-101 has been found to be safe and well tolerated in the clinical observation portion of the GLP Safety/Toxicology study of NV-HHV-101 as a dermal treatment.

  August 5, 2019

   · 

  5 min read
• Business

  Gossamer Bio to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019

  In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:30 p.m. ET on Thursday, August 8, 2019, to discuss the Company’s financial results and provide a corporate update.

  August 5, 2019

   · 

  1 min read
• Genetown

  ArQule to Participate in the BTIG Biotechnology Conference on Monday, August 12, 2019

  ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases.

  August 5, 2019

   · 

  1 min read
• Business

  Merck KGaA, Darmstadt, Germany and Universal Display Corporation Announce Collaboration to Further Advance OLED Technology

  Two key players in the OLED industry are collaborating to accelerate development of new products and for the advancement of OLED technology

  August 5, 2019

   · 

  5 min read